For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Goodfellow gems #79
Wednesday 23 May 2018, 01:00 AM

“Highlights from 2017 bpacnz antibiotic guide”
Shorter courses of antibiotics, more intensive dosing regimens and reserving broader-spectrum antibiotics for specific scenarios are some key message
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.